Ranbaxy Q110 Sales In Africa Rose By 30%

BMI View: Pharmaceutical firms in the emerging markets are targeting other emerging markets for growth. As these drugmakers are generic, reaching countries that have low per-capita spending and high populations will form a key part of strategies for both geographic expansion and revenue growth. To this end, Indian drugmakers are increasing both manufacturing in and exports to Africa, which has a heavy disease burden and therefore sustainable high demand for medicines. As an example, Ranbaxy's recent investor presentation highlights Africa as one of it high growth regions for sales.

To read the full article, please sign in or take a free trial.